# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5278465 | 33 | IC50 | > | 2 | uM | ALA5252932 | nM | Homo sapiens | |||
2. | ALA5270781 | 38 | IC50 | > | 2 | uM | ALA5252055 | nM | Homo sapiens | |||
3. | ALA5273533 | 37 | IC50 | > | 1000 | nM | ALA5244421 | nM | Homo sapiens | |||
4. | ALA5281283 | 18 | IC50 | > | 1000 | nM | ALA5244421 | nM | Homo sapiens | |||
5. | Ibrutinib (PCI-32765) | SID124898784 | IC50 | = | 11 | nM | ALA5242627 | 7.96 | nM | Homo sapiens | ||
6. | ALA5274179 | 41 | INH | 0 | ALA5240396 | Not Active | % | Homo sapiens | ||||
7. | mobocertinib | MOBOCERTINIB | INH | > | 81 | % | ALA5238876 | % | Homo sapiens | |||
8. | Zanubrutinib (BGB-3111) | BDBM250082 | IC50 | = | 56 | nM | ALA5213089 | 7.25 | nM | Homo sapiens | ||
9. | Zanubrutinib (BGB-3111) | BDBM250082 | IC50 | = | 3477 | nM | ALA5213088 | 5.46 | nM | Homo sapiens | ||
10. | Acalabrutinib (ACP-196) | ACALABRUTINIB | IC50 | > | 10 | uM | ALA5213052 | nM | Homo sapiens | |||
11. | ALA5169523 | 25 | INH | = | 5 | % | ALA5156290 | % | Homo sapiens | |||
12. | ALA5172397 | 36; TUL01101 | Activity | = | 87 | % | ALA5154560 | % | Homo sapiens | |||
13. | Ibrutinib (PCI-32765) | SID124898784 | IC50 | = | 33.7 | nM | ALA5145631 | 7.47 | nM | Homo sapiens | ||
14. | ALA5200804 | 1 | INH | 0 | ALA5145631 | NA | % | Homo sapiens | ||||
15. | ALA5193702 | 12n | INH | = | 40 | % | ALA5141354 | % | Homo sapiens | |||
16. | ALA5193702 | 12n | INH | = | 92 | % | ALA5141307 | % | Homo sapiens | |||
17. | ALA5185626 | 83 | IC50 | > | 49.5 | uM | ALA5140654 | nM | Homo sapiens | |||
18. | Acalabrutinib (ACP-196) | ACALABRUTINIB | IC50 | > | 1000 | nM | ALA5135833 | nM | Homo sapiens | |||
19. | Zanubrutinib (BGB-3111) | BDBM250082 | IC50 | = | 50 | nM | ALA5135833 | 7.30 | nM | Homo sapiens | ||
20. | Ibrutinib (PCI-32765) | SID124898784 | IC50 | = | 4.9 | nM | ALA5135833 | 8.31 | nM | Homo sapiens |